CIK 0001681087
- Non-accelerated filer
- Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 810710585
- Phone
- +1 339-666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,920
- in 2 filings, $14K under 10b5-1 plans
Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-17 | Donenberg Phillip B. Director | Purchase | +2,000 | $11.71 | $23K | 2,000 |
| 2021-02-04 | MACKAY GEOFFREY President & CEO | Grant or award · Stock Option (Right to Buy) | +343,850 | 343,850 | ||
| 2021-02-04 | Avruch Steven Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +98,200 | 98,200 | ||
| 2021-02-04 | Petersen Deanna M Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +86,600 | 86,600 | ||
| 2021-02-04 | Ostrowski Erik Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +119,100 | 119,100 | ||
| 2021-02-01 | Escolar Diana Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2020-12-24 | MACKAY GEOFFREY President & CEO | Exercise or conversion | +100,000 | $0.41 | $41K | 245,123 |
| 2020-12-24 | MACKAY GEOFFREY President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −100,000 | 142,013 | ||
| 2020-10-19 | Farfel Gail M Director | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2020-06-04 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2020-06-04 | Donenberg Phillip B. Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2020-06-04 | Jenkins Annalisa Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2020-06-04 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2020-06-04 | Vickers Philip J. Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2020-06-04 | PAIGE CHRISTOPHER Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2020-03-04 | Petersen Deanna M Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2020-03-04 | Volck Birgitte President of R&D | Grant or award · Stock Option (Right to Buy) | +76,000 | 76,000 | ||
| 2020-03-04 | Ostrowski Erik Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,900 | 100,900 | ||
| 2020-03-04 | MACKAY GEOFFREY President & CEO | Grant or award · Stock Option (Right to Buy) | +292,300 | 292,300 | ||
| 2020-03-04 | Avruch Steven Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 |
Page 13 of 17 · 322 trades